RANDAL J KIRK Insider Trading $OGEN ORAGENICS INC
Get free email notifications about insider trading for RANDAL J KIRK.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
Get the latest insider transactions of RANDAL J KIRK. RANDAL J KIRK is Director in CLINICAL DATA INC ($NOVI) and 10% Owner in AmpliPhi Biosciences Corp ($APHB) and 10% Owner in Fibrocell Science, Inc. ($FCSC) and 10% Owner in SOLIGENIX, INC. ($DOR) and 10% Owner in Synthetic Biologics, Inc. ($SYN) and 10% Owner in TRANSGENOMIC INC ($TBIO) and Director in ZIOPHARM ONCOLOGY INC ($ZIOP) and 10% Owner in HALOZYME THERAPEUTICS INC ($GYHT) and Director in HALOZYME THERAPEUTICS INC ($GYHT) and 10% Owner in ORAGENICS INC ($OGEN) and 10% Owner in INTREXON CORP ($XON) and Chief Executive Officer in INTREXON CORP ($XON) and Director in INTREXON CORP ($XON) and Executive Chairman in INTREXON CORP ($XON) and 10% Owner in HISTOGENICS CORP ($HSGX) and 10% Owner in AquaBounty Technologies, Inc. ($AQB).
RANDAL J KIRK in ORAGENICS INCTrading Symbol: OGEN
Industry: PHARMACEUTICAL PREPARATIONS 
Position of RANDAL J KIRK: 10% Owner
Holdings: 14,481,089 shares
Current Value: $11,005,628
Latest Transaction: Jul 05 2016
$OGEN Market Capitalization: $38.33M
$OGEN Previous Close: $0.76
Last 4 weeks trend: BUY
Last 3 months trend: BUY
Last 3 Months Overview:
Shares Bought: 2,261,419
Shares Sold: 0
Share Difference: +2,261,419
Value Difference: -$1,166,666
Latest Insider Trading Transactions of RANDAL J KIRK in ORAGENICS INC
|1 Week||2 Weeks||1 Month||3 Months||6 Months||1 Year||2 Years|
|No. of Purchases||0||0||0||0||0||0||0|
|Value of Purchases ($)||0||0||0||0||0||0||0|
|No. of Sales||0||0||0||0||0||0||0|
|Value of Sales ($)||0||0||0||0||0||0||0|
|Date||Ticker||Company||Owner||Relationship||Transaction||Code||Cost ($)||Shares||Transaction Value ($)||Total Shares||% Holdings|
|Jul 05 2016||OGEN||ORAGENICS INC||KIRK RANDAL J||10% Owner||Buy||P||0.52||2,261,419||1,166,666||14,481,089||12.2 M to 14.5 M (+18.51 %)|
|Dec 03 2015||OGEN||ORAGENICS INC||KIRK RANDAL J||10% Owner||Buy||C||1.50||3,381,004||5,071,506||12,219,670||8.8 M to 12.2 M (+38.25 %)|